Literature DB >> 30887263

Comparison of electroretinographic measurements between tabletop and handheld stimulators in healthy subjects.

Bum G Kim1, In B Chang2, Kyeong D Jeong3, Jae Y Park1, Jae S Kim1, Je Hyung Hwang4.   

Abstract

PURPOSE: To compare full-field electroretinography (ffERG) parameters obtained from handheld and tabletop electroretinography (ERG) devices in normal subjects.
METHODS: Twenty volunteers underwent ffERG using a tabletop and handheld stimulator. The responses obtained from the right eyes were compared. The coefficient of variation and intraclass correlation coefficient (ICC) were derived to assess inter- and intra-individual reliability.
RESULTS: The b-wave in the rod response, a- and b-waves in the maximal combined response, a-wave in the cone response, and the 30-Hz flicker response showed significantly greater amplitudes when recorded with the tabletop stimulator than with the handheld stimulator. The implicit time of response (ITR) in the 30-Hz flicker response was longer when recorded with the handheld stimulator than when recorded with the tabletop stimulator. With regard to amplitude, the ICC indicated moderate-to-high reliability in the measurement of the b-wave in the rod response, and a- and b-waves in the maximal combined response. With regard to ITR, measurement of the b-wave in the rod response and a-wave in the maximal combined response showed moderate-to-high reliability.
CONCLUSION: Despite the significantly lower ERG amplitude measurements recorded by the handheld stimulator, there were no significant differences in variability between the two stimulators.

Keywords:  Full-field electroretinography; Handheld stimulator; Normal subjects; Tabletop stimulator

Mesh:

Year:  2019        PMID: 30887263     DOI: 10.1007/s10633-019-09686-7

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  15 in total

1.  Guidelines for calibration of stimulus and recording parameters used in clinical electrophysiology of vision.

Authors:  Mitchell Brigell; Michael Bach; Colin Barber; Anne Moskowitz; John Robson
Journal:  Doc Ophthalmol       Date:  2003-09       Impact factor: 2.379

2.  Retinal capillary morphology in the Abyssinian cat with hereditary retinal degeneration.

Authors:  Christian Albrecht May; Kristina Narfström
Journal:  Exp Eye Res       Date:  2012-04-06       Impact factor: 3.467

3.  Amax to scotopic Imax diagnoses feline hereditary rod cone degeneration more efficiently than any other combination of long protocol electroretinogram parameters.

Authors:  Kristina Narfström
Journal:  Doc Ophthalmol       Date:  2008-01-10       Impact factor: 2.379

4.  Comparison between fullfield electroretinography obtained from handheld and tabletop devices in normal subjects.

Authors:  Ramya Sachidanandam; Vikas Khetan; Parveen Sen
Journal:  Can J Ophthalmol       Date:  2015-04       Impact factor: 1.882

5.  ISCEV Standard for full-field clinical electroretinography (2015 update).

Authors:  Daphne L McCulloch; Michael F Marmor; Mitchell G Brigell; Ruth Hamilton; Graham E Holder; Radouil Tzekov; Michael Bach
Journal:  Doc Ophthalmol       Date:  2014-12-14       Impact factor: 2.379

6.  ERG monitoring of retinal function during systemic chemotherapy for retinoblastoma.

Authors:  Scott E Brodie; Yannis M Paulus; Mrinali Patel; Y Pierre Gobin; Ira J Dunkel; Brian P Marr; David H Abramson
Journal:  Br J Ophthalmol       Date:  2012-03-18       Impact factor: 4.638

7.  Electroretinogram responses of the normal thoroughbred horse sedated with detomidine hydrochloride.

Authors:  Melanie L Church; Joanna C Norman
Journal:  Vet Ophthalmol       Date:  2012-04-12       Impact factor: 1.644

8.  Electroretinography in the prognosis and classification of central retinal vein occlusion.

Authors:  R Sabates; T Hirose; J W McMeel
Journal:  Arch Ophthalmol       Date:  1983-02

9.  Guidelines for clinical electroretinography in the dog: 2012 update.

Authors:  Björn Ekesten; András M Komáromy; Ron Ofri; Simon M Petersen-Jones; Kristina Narfström
Journal:  Doc Ophthalmol       Date:  2013-06-01       Impact factor: 2.379

10.  Persistence of retinal function after selective ophthalmic artery chemotherapy infusion for retinoblastoma.

Authors:  Scott E Brodie; Y Pierre Gobin; Ira J Dunkel; Jonathan W Kim; David H Abramson
Journal:  Doc Ophthalmol       Date:  2009-01-25       Impact factor: 2.379

View more
  1 in total

1.  Comparing the RETeval® portable ERG device with more traditional tabletop ERG systems in normal subjects and selected retinopathies.

Authors:  Jia Yue You; Allison L Dorfman; Mathieu Gauvin; Dylan Vatcher; Robert C Polomeno; John M Little; Pierre Lachapelle
Journal:  Doc Ophthalmol       Date:  2022-10-23       Impact factor: 1.854

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.